First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with EGFR mutation (CONVINCE)
| Autor: | L. Wang, C. Yao, X. Song, C. Ding, Baohui Han, F. Tan, X. Ren, Y-K. Shi, Y. Song, Z. Ma, L. Ding, Huilai Zhang, N. Wu, G. Chen, X. Han, Wei Li, Yiliang Ellie Liu, Shutian Zhang, J. Feng, P. Yu |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty Lung business.industry First line Hematology medicine.disease 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Pemetrexed medicine.anatomical_structure Maintenance therapy Egfr mutation 030220 oncology & carcinogenesis Internal medicine Icotinib medicine Adenocarcinoma business medicine.drug |
| Zdroj: | Annals of Oncology. 27:vi425 |
| ISSN: | 0923-7534 |
| DOI: | 10.1093/annonc/mdw383.29 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|